How should postoperative warming be managed in a patient after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) to prevent hypothermia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postoperative Warming After HIPEC

Active warming devices (forced-air warming blankets and warmed intravenous fluids) should be applied immediately upon arrival to the ICU and continued until core temperature is maintained above 36°C, with continuous core temperature monitoring (esophageal, bladder, or rectal) to prevent rebound hypothermia—a specific and dangerous complication after HIPEC.

Understanding the Unique Risk: Rebound Hypothermia After HIPEC

Post-HIPEC patients face a paradoxical temperature challenge distinct from standard surgery:

  • Rebound hypothermia occurs in the immediate postoperative period despite intraoperative hyperthermia, and has been associated with cardiac arrest in multiple case reports 1
  • The incidence of hypothermia on ICU arrival is 57.8% in general postoperative patients, but HIPEC patients face additional risk from massive fluid shifts (median 8.4 liters), prolonged surgery (median 715 minutes), and significant blood loss 2, 3
  • Core temperature typically decreases 1.6°C in the first hour after anesthesia, with 81% of this decrease due to redistribution 2

Immediate Postoperative Warming Protocol

Core Temperature Monitoring (Mandatory)

  • Continuous core temperature monitoring (bladder, esophageal, or rectal) is strongly recommended over superficial measurements (skin, tympanic) for major surgery 4
  • Temperature should be documented continuously, not intermittently, as hypothermia is poorly recognized in 62% of trauma admissions 2
  • Target: maintain core temperature >36°C 5

Active Warming Interventions

Primary warming methods (apply simultaneously):

  • Forced-air warming blankets: Most effective active warming device for postoperative patients 2, 4, 5
  • Warmed intravenous fluids: All IV fluids should be administered through fluid warming devices 2, 4, 5
  • Increase ambient temperature: ICU room temperature should be maintained at 21-25°C 4

Fluid Management Considerations

  • Avoid cold fluid administration, as this is an independent risk factor for postoperative hypothermia 2, 3
  • Be aware that HIPEC patients receive massive fluid volumes (median 8.4 liters intraoperatively), making warmed fluid administration critical 3
  • Balanced crystalloid solutions are preferred over 0.9% sodium chloride 2

Critical Pitfalls to Avoid

The Rebound Hypothermia Phenomenon

  • Do not assume normothermia based on intraoperative hyperthermia during HIPEC (41-43°C perfusate temperature) 6, 7
  • Rebound hypothermia can occur rapidly despite active intraoperative cooling measures 1, 8
  • This complication has been associated with cardiac arrest when combined with hypokalemia and metabolic derangements 1

Metabolic Monitoring

  • Monitor potassium levels closely, as hypokalemia combined with hypothermia increases cardiac arrest risk 1
  • Hypothermia decreases insulin sensitivity and secretion, causing hyperglycemia 4

Consequences of Inadequate Warming

  • Hypothermia <34°C carries >80% independent mortality risk after controlling for other factors 4
  • Even mild hypothermia increases blood loss by 16% and transfusion risk by 22% 2, 4
  • Hypothermia profoundly impairs platelet function (33-37°C) and coagulation factor activity (<33°C) 4

Duration of Active Warming

  • Continue active warming measures until core temperature is stably maintained above 36°C without assistance 5
  • Given the median hospital stay of 8-24 days post-HIPEC, temperature monitoring should extend beyond the immediate postoperative period 7
  • Independent risk factors for persistent hypothermia include surgery duration >3 hours, general anesthesia, and cold fluid administration—all present in HIPEC procedures 2

Special Considerations for HIPEC Patients

  • The combination of massive blood loss (median 0.8 liters), large fluid shifts, prolonged operative time, and metabolic disturbances makes HIPEC patients particularly vulnerable 3
  • Warming devices and higher early temperatures are protective factors against postoperative hypothermia 2
  • Remove any wet surgical drapes or clothing immediately, as this contributes to ongoing heat loss 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Temperatura Ideal Durante el Acto Operatorio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Perioperative Hypothermia-A Narrative Review.

International journal of environmental research and public health, 2021

Guideline

Intra‑operative Precautions for HIPEC with Mitomycin C

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clinical Guidelines for HIPEC in Ovarian Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.